Roche Announces Changes In Board Of Directors; Andreas Oeri To Retire From Board
Novartis Announces Data From 52-week Pivotal Phase III PALLADIUM Trial
Lexicon Announces Positive Topline Data From Phase 1 Study Of LX9211
GlaxoSmithKline: ViiV Healthcare Submits NDA To FDA For Fostemsavir
Novartis Holds An Investor Event In London; Expects To Sustain Long-term Growth
Novartis Says Tender Offer For The Medicines Co. Begins